The expression of SREBP2 increased in lung samples of IPF patients, and SREBP2 overexpression induces EndMT, leading to activation of TGF and Wnt signaling, increased ECM deposition, and aggravation of pulmonary fibrosis [172] (Figure 5). This evidence concerns the gene SREBF2 and pulmonary fibrosis.